WHIPgroup has filed a Complaint before the United States International Trade Commission (ITC) on behalf of its client RegenLab USA. The Complaint alleges that RegenLab’s US Pat. No. 10.064,894, directed to a blood separator system for the preparation of platelet rich plasma, has been infringed by Estar Technologies, Ltd. and Eclipse MedCorp., LLC. RegenLab is seeking an exclusion order from the ITC to prevent importation of infringing products. The ITC instituted a formal investigation on March 7, 2019. The case is captioned In the Matter of Certain Blood Separation and Cell Preparation Devices, Inv. No. 337-TA-1147.
Under U.S. law, anyone who uses a system that is likely to have been made by a patented process, and who does not demonstrate that the system was not made by the patented process, is [Read More…]
Recently, WHIPGROUP engaged in an arbitration that included a five day hearing in the City. Here are some thoughts about why arbitration is different (not clearly better or worse) than litigation. Venue The AAA arbitral [Read More…]
WHIPGroup previously filed a Motion to Dismiss a patent infringement suit filed against its client TomTom in the Western District of Texas. Rather than opposing WHIPGroup’s motion to dismiss, Plaintiff MDSP Technologies LLC voluntarily dismissed [Read More…]